FDA approves La Jolla's low blood pressure drug
(Reuters) - La Jolla Pharmaceutical said on Thursday the U.S. Food and Drug Administration had approved its drug, Giapreza, to treat dangerously low blood pressure.
from Reuters: Health News http://reut.rs/2Bvu6XN
http://bit.ly/2zwRqiM
December 21, 2017
|
Labels:
health,
Reuters: Health News
|
This entry was posted on December 21, 2017
and is filed under
health
,
Reuters: Health News
.
You can follow any responses to this entry through
the RSS 2.0 feed.
or trackback from your own site.